(Q54256001)

26 May 2018

title

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma. (English)

1 reference

26 May 2018

author name string

P L Zinzani

1

1 reference

26 May 2018

M Bendandi

2

1 reference

26 May 2018

M Magagnoli

3

1 reference

26 May 2018

F Gherlinzoni

4

1 reference

26 May 2018

E Merla

5

1 reference

26 May 2018

S Tura

6

1 reference

26 May 2018

publication date

1 April 1997

1 reference

26 May 2018

published in

Annals of Oncology

1 reference

26 May 2018

volume

8

1 reference

26 May 2018

issue

4

1 reference

26 May 2018

page(s)

379-383

1 reference

26 May 2018

Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Stage I-II follicular lymphoma. Treatment results for 76 patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Updated Kiel classification for lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

High dose chemotherapy with autologous marrow transplantation in follicular lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008228709612

7 January 2021

Identifiers

DOI

10.1023/A:1008228709612

1 reference

26 May 2018

PubMed ID

9209669

1 reference

26 May 2018